Beijing is struggling to rein in the self-preservation instincts of small investors.

Jerusalem-based Teva is said to be close to an agreement to acquire Dublin-based Allergan’s generic drugs unit for between $40 billion and $45 billion.

Chicago’s other school of economics.

The Federal Reserve’s new capital rules require JPMorgan to hold more capital than its lending-focused rival, but it’s not clear Wells Fargo has less to lose.

It processed $30 billion in payments last year.

The real reasons to worry have nothing to do with the markets.

Big business lobbyists take aim at “Big Business.”

It wants to retain heirs for the future.